Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain

Clinical trial NCT02270983 · COMPLETED

Trial details

NCT number: NCT02270983
Sponsor: Forest Laboratories
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Opioid-Induced Constipation

Start date: 2014-10-31
Primary completion: 2015-08-31
Enrollment: 254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.